Has Jeremy Joyal, MD received payments from drug or device companies?

Yes. Drug and device makers reported $170,062 in general payments to Jeremy Joyal, MD across 912 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jeremy Joyal, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jeremy Joyal, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jeremy Joyal, MD

Pain Medicine · Draper, UTNPI 1861622219

Payments from drug & device makers

$170,062in general payments, 2019–2025

Across 912 payments — averaging $186.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$110K
Relievant Medsystems, Inc.$34K
MML US, Inc.$18K
Medtronic$3K
AbbVie$951
Biotronik NRO, Inc.$604
plus $4K from 40 others

What the payments were for

Consulting fees$19,40911%
Speaking & faculty fees$115,15068%
Travel & lodging$14,2908%
Food & beverage$21,12812%
Education$850%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	349	$109,897
Relievant Medsystems, Inc.	111	$34,280
MML US, Inc.	56	$17,965
Medtronic(2 entities)	174	$2,652
AbbVie(2 entities)	50	$951
Biotronik NRO, Inc.	14	$604
Saluda Medical Americas, Inc.	6	$385
SPR Therapeutics, Inc	7	$384
Nalu Medical, Inc.	16	$312
Merz Pharmaceuticals, LLC	6	$263
Zyla Life Sciences, Inc.	24	$213
Abbott	6	$213
Vertos Medical, Inc.	7	$190
Collegium Pharmaceutical, Inc.	11	$178
Nevro Corp.	7	$161
Painteq LLC	4	$134
Globus Medical	3	$126
Radius Health, Inc.	2	$111
Johnson & Johnson	4	$100
Averitas Pharma Inc.	4	$93
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	5	$88
Biohaven Pharmaceutical Holding Company Ltd.	4	$66
Alphatec Spine, Inc	1	$55
Bioventus LLC	4	$50
Sanofi-aventis U.S. LLC	2	$47
Pfizer	3	$46
Impel Pharmaceuticals Inc.	3	$45
Lilly USA, LLC	3	$42
Biodelivery Sciences International, Inc.	3	$39
Spinal Simplicity, LLC	2	$37
Si-bone, Inc.	2	$36
Vertex	2	$34
Virtus Pharmaceuticals LLC	2	$31
Tersera Therapeutics LLC	2	$30
Indivior Inc.	2	$30
Hydrocision, Inc.	1	$27
Merz North America, Inc.	1	$22
Pear Therapeutics (US), Inc.	1	$21
Almatica Pharma LLC	1	$17
Lundbeck LLC	1	$16
Idorsia Pharmaceuticals US Inc	1	$14
International Rehabilitative Sciences, Inc	1	$13
Redhill Biopharma Inc.	1	$13
Alkermes, Inc.	1	$12
Acacia Pharma Inc	1	$12
Stratus Medical, LLC	1	$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$170,062 in reported general payments places this provider in the 95th percentile of 61 pain medicine providers in Utah.

See all pain medicine providers in Utah →

Medicare billing

Part B allowed, 2024

$407,035

Medicare patients

390

Services billed

10,080

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	25	$383
Tizanidine Hcl	47	$343
Pregabalin	13	$269
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	13	$227
Cephalexin	14	$94
Meloxicam	14	$60

Paid to pharmacies, not to this prescriber.

Other pain medicine in Draper

Derek HaightDraper$78K
Braden WebbDraper$12K
Lynn WebsterSalt Lake City$1.7M
Maria SchwartzSalt Lake City$813K
Benjamin HumpherysLayton$120K
Jon ObraySt George$24K
Jason BeckstrandWest Jordan$17K
Austin AlbrightSalt Lake City$14K
Derek FriedenSt. George$14K
Jeffrey PenceWest Valley City$13K

See the full list for Utah →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →